BioFlo PICC with ENDEXO and PASV Valve Technology, Maximal Barrier Nursing Kit, UPN H965750211 T...
FDA Device Recall #Z-1985-2016 — Class II — March 14, 2016
Recall Summary
| Recall Number | Z-1985-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 14, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Navilyst Medical, Inc., an AngioDyamics Company |
| Location | Glens Falls, NY |
| Product Type | Devices |
| Quantity | 445 units |
Product Description
BioFlo PICC with ENDEXO and PASV Valve Technology, Maximal Barrier Nursing Kit, UPN H965750211 The Xcela PICC with PASV, Xcela Hybrid PICC with PASV, BioFlo PICC with PASV and BioFlo Hybrid PICC with PASV are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. Non-valve lumens are indicated for central venous pressure monitoring
Reason for Recall
PICC catheters that contain valve(s) manufactured prior to July 15, 2014 lack a manufacturing specification change that reduces the incidence of hemolysis during blood sampling through the PICC catheter.
Distribution Pattern
Worldwide Distribution US (Nationwide) Internationally to AU, GR, SE, SA, IN, CA, GB, BR, BE, NL, ES, KR, HK, AE, IT and ES.
Lot / Code Information
Batch/Lots: 4773627, 4780053 & 4782468. Use By Date Range 2016-05-31 to 2016-07-31
Other Recalls from Navilyst Medical, Inc., an AngioDyami...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1966-2016 | Class II | Vaxcel PICC with PASV Catheter Kit under the fo... | Mar 14, 2016 |
| Z-1967-2016 | Class II | Vaxcel PICC with PASV Introducer Kit under the ... | Mar 14, 2016 |
| Z-1984-2016 | Class II | BioFlo PICC with ENDEXO and PASV Valve Technolo... | Mar 14, 2016 |
| Z-1973-2016 | Class II | Xcela PICC with PASV Valve Technology Catheter ... | Mar 14, 2016 |
| Z-1981-2016 | Class II | BioFlo PICC with ENDEXO and PASV Valve Technolo... | Mar 14, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.